We would love to hear your thoughts about our site and services, please take our survey here.
Dont disagree with you, think she is a waste of space, but let her deliver on the strategy and then get rid of her. But dont think it is solely her fault. Previous idiots sold off oncology and didnt invest enough.
If we follow Astra lead, yes divi income will hurt, the growth will outgrow and make up for it.
I dont disagree, in the US, the companies are known to be poor income payers, they have always chased for growth. Was just citing a possible reason why it does not go up. Also if if you look at the dividends, at first it looked like they have no intention of increasing and would be subject to board approvals. But, if you look at slide 13 https://www.bp.com/content/dam/bp/business-sites/en/global/corporate/pdfs/investors/bp-first-quarter-2021-results-presentation-slides-and-script.pdf the dividend cash is flat (Dark green) but if the share buy back (light green) start increasing, then they can increase dividends without increasing the absolute amounts, which is good. That make this more attractive and the increase cost savings will make the business cash richer. To possibly increase investments in renewables aswell as cutting down the debt.
It has lagged to oil, but remember dividends were cut and i feel they are waiting to see how the oil demand pans out. this has been held back, but oil higher than $45 it is a cash generative business.
Yes the share price is the main reason here, but it is not a surprise and had to be cut, due to poor management decisions in the past.
She is out of her depth, but given a chance, but she can not run the pharma business post spin off.
This will be a better company in the mid to long term.
Denby people are aware of the share dividend cuts, i wouldnt listen to people on money.com commenting, most are clueless.
Yes it may drop but it has risen and what is being shared in that article is nothing new really.
Longfell, if that is the scenario, and agree, NVS should simply say "ok it takes time, when the EA comes no extension and you can compete with the rest of the market"
A deal can be structured for both to mitigate, AA can go and look at other assets and regret not getting ours.
Smallholding, great post, a different perspective that sounds plausible.
I was just reading between the lines with what the company is getting out there and as we are fast approaching the deadline, it feels nuts that we would get something in next 2/3 weeks, i am now pessimistic getting a deal before the Deadline that i was previously which was optimistic and a deal before April.
Anglo have had a lot of time, from last year after due diligence to present an offer, we don't know what is happening in the background, but it is in Rothschild's interest to secure a good deal. I don't want ARCM to sell the assets too cheaply.
If Anglo cant present an offer that is attractive, to me it feels like they are not the right partners and want to take advantage, if that transpires, I really wish we go ahead with the small mine next year and we open up to the market and no longer offer them exclusivity.
We should find out soon enough what is happening and I know the investment case here shows we are worth multiples however long it takes. One thing would be unforgivable is after stating no further cash raises and we had one, but i understand the reasons they do another, i really would have an issue, the guys are smart and know they can not repeat that, so see how this plays out and we look forward to the mine next year if need be.
GLA
TBH If AAL cant do a sensible deal now, and if it is based on what kind of deal and the terms, i.e. we meed to drill more to prove up.
I rather we did not give them an extension and say you had your chance, we can go it alone and open up to the wider market.
They have had enough time to propose a decent offer that would leave upside for ARCM but not be too risky for them, especially as they can raise the cash or share offer very easily. As someone mentioned a few weeks ago, i think a lot of time and effort was demerging the coal business and this will be one of many. There are reports of issues with that demerger https://www.cityam.com/anglo-american-south-african-coal-mines-are-worthless-says-researcher-in-scathing-attack/
How are we doing with further drilling? that should be well progressing now, presume that is news that will drop in the next few weeks or is that unrealistic and requires more time?
Really surprised that from the 6th May the investor call has not been shared on Twitter, makes no sense unless they mentioned something Anglo was not happy with and hence not shared.
TR64 I am not a supporter for Elliott and know they are looking at short term gains again I have posted this, I said they along with a long term investor are showing disapproval.
EW should see out her strategy but then go she is out of her depth , she may have got Hal but she has lost a few also. She can not run the pharma business post 2022 she is not good enough and Aviva agree so far. I do not blame she is at fault but she should be partly blamed, she has made some good acquisitions but the share price has underperformed.
TR64 if you learnt how to read English you will understand your response doesn’t Grasp what I was saying . Assume your responding to me as you have not made it clear.
I’m not talking about the vaccine for covid I have talked about that before and my views already have a look on my view of you don’t understand it.
Compare the share price between Astra and GSK at least the last 5 years, Astra has doubled, GSK has fallen 5%.
Proves to you what a decent CEO can do, Emma isnt a decent CEO, has connections who plays her trumpet and promotes her, but as shareholders people know she is a waste of space.
WIth Elliott on board and Aviva showing impatience, she would need to exit once her strategy is completed. She has been around for far too long and is not the right person, you can continue to say throw money at something, but they need to look at how they operate. The truth is the dividend can be cut and i am for it, i rather we grow than get a secure income for now. If you look at the US the valuations are nuts but they have always paid poorly when it comes to dividends as they always look at capital growth and it pays off. The dividend is c £4bn and they can reduce by £1-1.5bn a year.. Debt is cheap so if they want more cash can raise the debt levels.
The UK
If we are confident APR I rather we de risked one location for a percentage that is acceptable and AAl starts mass exploring. We don’t need to sell cheap and majors need access to copper.
If we get another investor relations call and nothing comes about with AAL I will push for the company to put that aside and focus on value for us as we are wasting time with one party.
They are having the convos and I’m hoping they really see value in the discussions being had. What is interesting what Rothschild are doing as they will be paid a percentage on any deal accepted so they need to make it worth their while.